Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study

BACKGROUND Alleles of the apolipoprotein E (APOE) gene modulate risk for Alzheimer's disease, with carriers of the epsilon4 allele being at increased risk and carriers of the epsilon2 allele possibly at decreased risk compared with non-carriers. Our aim was to determine whether possession of an epsilon4 allele would confer children with a neural substrate that might render them at risk for Alzheimer's disease, and whether carriers of the epsilon2 allele might have a so-called protective cortical morphology. METHODS 239 healthy children and adolescents were genotyped and had repeated neuroanatomic MRI (total 530 scans). Mixed model regression was used to determine whether the developmental trajectory of the cortex differed by genotype. FINDINGS Cortical thickness of the left entorhinal region was significantly thinner in epsilon4 carriers than it was in non-epsilon4 carriers (3.79 [SE 0.06] mm, range 1.54-5.24 vs 3.94 [0.03] mm, 2.37-6.11; p=0.03). There was a significant stepwise increase in cortical thickness in the left entorhinal regions, with epsilon4 carriers having the thinnest cortex and epsilon2 carriers the thickest, with epsilon3 homozygotes occupying an intermediate position (left beta 0.11 [SE 0.05], p=0.02). Neuroanatomic effects seemed fixed and non-progressive, with no evidence of accelerated cortical loss in young healthy epsilon4 carriers. INTERPRETATION Alleles of the apolipoprotein E gene have distinct neuroanatomic signatures, identifiable in childhood. The thinner entorhinal cortex in individuals with the epsilon4 allele might contribute to risk of Alzheimer's disease.

[1]  H. Pollard,et al.  Annexin 5 and apolipoprotein E2 protect against Alzheimer’s amyloid-β-peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site , 2002, Peptides.

[2]  R. Guerrant,et al.  APOE4 Protects the Cognitive Development in Children with Heavy Diarrhea Burdens in Northeast Brazil , 2005, Pediatric Research.

[3]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[4]  Thomas E. Nichols,et al.  Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.

[5]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[6]  Gene E. Alexander,et al.  Volumes of Medial Temporal Lobe Structures in Patients with Alzheimer’s Disease and Mild Cognitive Impairment (and in Healthy Controls) , 1998, Biological Psychiatry.

[7]  J. Price,et al.  Architectonic subdivision of the human orbital and medial prefrontal cortex , 2003, The Journal of comparative neurology.

[8]  Alan C. Evans,et al.  Volumetry of temporopolar, perirhinal, entorhinal and parahippocampal cortex from high-resolution MR images: considering the variability of the collateral sulcus. , 2002, Cerebral cortex.

[9]  S. Black,et al.  Beyond the hippocampus , 2001, Neurology.

[10]  Nick C. Fox,et al.  Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial magnetic resonance images , 2002 .

[11]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[12]  D A Bennett,et al.  The apolipoprotein E epsilon 2 allele and decline in episodic memory. , 2002, Journal of neurology, neurosurgery, and psychiatry.

[13]  Y. Stern,et al.  APOE related alterations in cerebral activation even at college age , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  Alan C. Evans,et al.  Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. , 2004, Cerebral cortex.

[15]  J W Keeling,et al.  The distribution of apolipoprotein E alleles in Scottish perinatal deaths , 2005, Journal of Medical Genetics.

[16]  I. Deary,et al.  The influence of the e4 allele of the apolipoprotein E gene on childhood IQ, nonverbal reasoning in old age, and lifetime cognitive change , 2003 .

[17]  H. Soininen,et al.  Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. , 1999, AJNR. American journal of neuroradiology.

[18]  J. Mazziotta,et al.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Strittmatter,et al.  Apolipoprotein E and brain injury: implications for children , 2005, Developmental medicine and child neurology.

[20]  P. Huttenlocher,et al.  Regional differences in synaptogenesis in human cerebral cortex , 1997, The Journal of comparative neurology.

[21]  Alan C. Evans,et al.  Cortical thickness analysis examined through power analysis and a population simulation , 2005, NeuroImage.

[22]  Alan C. Evans,et al.  Measurement of Cortical Thickness Using an Automated 3-D Algorithm: A Validation Study , 2001, NeuroImage.

[23]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[24]  Alan C. Evans,et al.  Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis , 2002, IEEE Transactions on Medical Imaging.

[25]  M. Mattson,et al.  A Mechanism for the Neuroprotective Effect of Apolipoprotein E , 2000, Journal of neurochemistry.

[26]  G. Murray,et al.  The association between APOE « 4 , age and outcome after head injury : a prospective cohort study , 2005 .

[27]  Alan C. Evans,et al.  Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification , 2005, NeuroImage.

[28]  M. Bobinski,et al.  Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[30]  D. Louis Collins,et al.  Automatic 3‐D model‐based neuroanatomical segmentation , 1995 .

[31]  G. Alexander,et al.  Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism , 2005 .

[32]  Charles D. Smith,et al.  Women at risk for AD show increased parietal activation during a fluency task , 2002, Neurology.

[33]  Suzanne E. Welcome,et al.  Longitudinal Mapping of Cortical Thickness and Brain Growth in Normal Children , 2022 .

[34]  D. Collins,et al.  Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.

[35]  V. Carey,et al.  Mixed-Effects Models in S and S-Plus , 2001 .

[36]  G. V. Van Hoesen,et al.  Orbitofrontal cortex pathology in Alzheimer's disease. , 2000, Cerebral cortex.

[37]  B. Tycko,et al.  APOE-dependent PET patterns of brain activation in Alzheimer disease , 2004, Neurology.

[38]  Jagath C. Rajapakse,et al.  Quantitative Magnetic Resonance Imaging of Human Brain Development: Ages 4–18 , 1996 .

[39]  B. Teter,et al.  Neuroplasticity in Alzheimer's disease , 2002, Journal of neuroscience research.

[40]  Margaret A. Pericak-Vance,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease , 1997 .

[41]  C. Jack,et al.  Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.

[42]  B. Winblad,et al.  Risk and protective effects of the APOE gene towards Alzheimer’s disease in the Kungsholmen project: variation by age and sex , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[43]  Kewei Chen,et al.  Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Braak,et al.  High Frequency of Apolipoprotein E ϵ4 Allele in Young Individuals with Very Mild Alzheimer's Disease-Related Neurofibrillary Changes , 1998, Experimental Neurology.

[45]  D. Bates,et al.  Mixed-Effects Models in S and S-PLUS , 2001 .

[46]  Alan C. Evans,et al.  Automated 3-D Extraction of Inner and Outer Surfaces of Cerebral Cortex from MRI , 2000, NeuroImage.

[47]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[48]  A. Minkowski,et al.  Regional Development of the Brain in Early Life , 1968 .

[49]  Alan C. Evans,et al.  A novel quantitative cross-validation of different cortical surface reconstruction algorithms using MRI phantom , 2006, NeuroImage.

[50]  H. Braak,et al.  Pattern of brain destruction in Parkinson's and Alzheimer's diseases , 2005, Journal of Neural Transmission.

[51]  C. Duyckaerts,et al.  Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer’s disease , 1998, Acta Neuropathologica.

[52]  Lars Bäckman,et al.  Apolipoprotein E and cognitive performance: a meta-analysis. , 2004, Psychology and aging.

[53]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[54]  Alan C. Evans,et al.  Intellectual ability and cortical development in children and adolescents , 2006, Nature.

[55]  S. DeKosky,et al.  Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. , 2000, Archives of neurology.

[56]  P. Yakovlev,et al.  The myelogenetic cycles of regional maturation of the brain , 1967 .

[57]  R. Katzman.,et al.  Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia , 1997, Neurology.

[58]  S. Leurgans,et al.  MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD , 2004, Neurobiology of Aging.

[59]  G. Murray,et al.  The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. , 2005, Brain : a journal of neurology.

[60]  David A. Bennett,et al.  The apolipoprotein E ε2 allele and decline in episodic memory , 2002 .

[61]  Kiralee M. Hayashi,et al.  Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia , 2004, NeuroImage.

[62]  Matthias Orth,et al.  Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration , 1999, The Journal of Neuroscience.

[63]  R. Plomin,et al.  No association between apolipoprotein E polymorphisms and general cognitive ability in children , 2001, Neuroscience Letters.